Acceptance of annual awards of shares in terms of the deferred portion of the Single Incentive Plan (“SIP”)
DISCOVERY LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1999/007789/06)
Legal Entity Identifier: 378900245A26169C8132
JSE share code: DSY, DSBP
DSY ISIN: ZAE000022331
DSBP ISIN: ZAE000158564
Bond company code: DSYI
(the "Group" or "Discovery" or the "Company")
ACCEPTANCE OF ANNUAL AWARDS OF SHARES IN TERMS OF THE DEFERRED PORTION OF THE SINGLE INCENTIVE PLAN ("SIP")
In compliance with paragraphs 3.63 to 3.74 and paragraphs 6.45 to 6.56 of the JSE Limited Listings Requirements and Debt and Specialist Securities Listings Requirements
respectively, notification is hereby given that certain executive directors and a prescribed officer of the Company, directors of major subsidiaries and the Group company secretary
have accepted annual awards of ordinary shares allocated in terms of the deferred portion of the SIP through the Discovery Long-Term Incentive Plan Trust ("LTIP Trust"). The
deferred portion of the SIP is awarded based on the performance criteria as per the SIP for the year ended 30 June 2024 and is settled in equity held on behalf of participants by
the LTIP Trust. The share awards of the deferred portion of the SIP are subject to continued employment.
The nature of the interest in respect of each of these awards is indirect beneficial. The transactions have occurred off-market and the necessary clearances have been obtained.
The details are set out below:
Executive Director of Discovery Limited Number of shares accepted Acceptance dates Reference Price* (all figures in R) Deemed Transaction Value (all
figures in R)
A Gore 61 760 27 November 2024 172.01 10 623 338
DM Viljoen 50 910 27 November 2024 172.01 8 757 029
B Swartzberg 90 952 (Note 1) 26 November 2024 172.01 15 644 654
Executive directors' share awards vest equally from the 3rd to the 5th anniversaries of these awards (between 30 September 2027 and 30 September 2029).
(Note 1) Includes award in respect of Vitality Global Outperformance Plan
Prescribed officer, directors Number of shares Company Acceptance dates Reference Price* Deemed Transaction
of major subsidiaries and accepted (all figures in R) Value (all figures in R)
Group company secretary
HD Kallner 141 234 (Note 2) Discovery Limited (prescribed officer) 26 November 2024 172.01 24 293 660
J Broomberg 83 729 (Note 3) Discovery Health 26 November 2024 172.01 14 402 225
F Chothia 12 736 Discovery Health 27 November 2024 172.01 2 190 719
A Ntsaluba 35 807 Discovery Health 26 November 2024 172.01 6 159 162
N Pitje 10 620 Discovery Health 27 November 2024 172.01 1 826 746
RM Whelan 20 026 Discovery Health 26 November 2024 172.01 3 444 672
SA Cohen 10 988 Discovery Life 26 November 2024 172.01 1 890 046
KS Rabson 28 530 Discovery Life 26 November 2024 172.01 4 907 445
RJ Van Reenen 26 815 Discovery Life 26 November 2024 172.01 4 612 448
AC Ceba 7 117 Discovery Limited (Group company secretary) 27 November 2024 172.01 1 224 195
The Prescribed officer, directors of major subsidiaries and the Group company secretary's share awards vest equally from the 1st to the 3rd anniversaries of these awards
(between 30 September 2025 and 30 September 2027).
* Consistent with the scheme rules and prior years, the reference price has been used in determining the share allocations and represents volume weighted average traded
price of the Company's shares for the 5 days ended 30 September 2024.
Sandton
29 November 2024
Equity Sponsor
Rand Merchant Bank (a division of FirstRand Bank Limited)
Debt Sponsor
FirstRand Bank Limited
(Note 2) Includes award in respect of special Outperformance SIP (on- target value reduced with increase in reward for stretch performance)
(Note 3) Includes award in respect of Vitality Global Outperformance Plan
Date: 29-11-2024 04:07:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.